Durvalumab vs Simvastatin

Durvalumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between Durvalumab and Simvastatin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Simvastatin — 2 hours.

Chemical Properties

Molecular Formula: Simvastatin — C25H38O5.

Molecular Weight: Simvastatin — 418.5700 g/mol.

Type: Durvalumab — Antibody; Simvastatin — Small molecule.